SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021

By August 2021, South Africa experienced three SARS-CoV-2 waves; the second and third associated with emergence of Beta and Delta variants respectively. We conducted a prospective cohort study during July 2020-August 2021 in one rural and one urban community. Mid-turbinate nasal swabs were collected...

Full description

Saved in:
Bibliographic Details
Published inmedRxiv : the preprint server for health sciences
Main Authors Cohen, Cheryl, Kleynhans, Jackie, von Gottberg, Anne, McMorrow, Meredith L, Wolter, Nicole, Bhiman, Jinal N, Moyes, Jocelyn, du Plessis, Mignon, Carrim, Maimuna, Buys, Amelia, Martinson, Neil A, Kahn, Kathleen, Tollman, Stephen, Lebina, Limakatso, Wafawanaka, Floidy, du Toit, Jacques, Xavier Gómez-Olivé, Francesc, Dawood, Fatimah S, Mkhencele, Thulisa, Sun, Kaiyun, Viboud, Cécile, Tempia, Stefano
Format Journal Article
LanguageEnglish
Published United States 04.12.2021
Online AccessGet more information

Cover

Loading…
Abstract By August 2021, South Africa experienced three SARS-CoV-2 waves; the second and third associated with emergence of Beta and Delta variants respectively. We conducted a prospective cohort study during July 2020-August 2021 in one rural and one urban community. Mid-turbinate nasal swabs were collected twice-weekly from household members irrespective of symptoms and tested for SARS-CoV-2 using real-time reverse transcription polymerase chain reaction (rRT-PCR). Serum was collected every two months and tested for anti-SARS-CoV-2 antibodies. Among 115,759 nasal specimens from 1,200 members (follow-up rate 93%), 1976 (2%) were SARS-CoV-2-positive. By rRT-PCR and serology combined, 62% (749/1200) of individuals experienced ≥1 SARS-CoV-2 infection episode, and 12% (87/749) experienced reinfection. Of 662 PCR-confirmed episodes with available data, 15% (n=97) were associated with ≥1 symptom. Among 222 households, 200 (90%) had ≥1 SARS-CoV-2-positive individual. Household cumulative infection risk (HCIR) was 25% (213/856). On multivariable analysis, accounting for age and sex, index case lower cycle threshold value (OR 3.9, 95%CI 1.7-8.8), urban community (OR 2.0,95%CI 1.1-3.9), Beta (OR 4.2, 95%CI 1.7-10.1) and Delta (OR 14.6, 95%CI 5.7-37.5) variant infection were associated with increased HCIR. HCIR was similar for symptomatic (21/110, 19%) and asymptomatic (195/775, 25%) index cases (p=0.165). Attack rates were highest in individuals aged 13-18 years and individuals in this age group were more likely to experience repeat infections and to acquire SARS-CoV-2 infection. People living with HIV who were not virally supressed were more likely to develop symptomatic illness, and shed SARS-CoV-2 for longer compared to HIV-uninfected individuals. In this study, 85% of SARS-CoV-2 infections were asymptomatic and index case symptom status did not affect HCIR, suggesting a limited role for control measures targeting symptomatic individuals. Increased household transmission of Beta and Delta variants, likely contributed to successive waves, with >60% of individuals infected by the end of follow-up. Previous studies have generated wide-ranging estimates of the proportion of SARS-CoV-2 infections which are asymptomatic. A recent systematic review found that 20% (95% CI 3%-67%) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections remained asymptomatic throughout infection and that transmission from asymptomatic individuals was reduced. A systematic review and meta-analysis of 87 household transmission studies of SARS-CoV-2 found an estimated secondary attack rate of 19% (95% CI 16-22). The review also found that household secondary attack rates were increased from symptomatic index cases and that adults were more likely to acquire infection. As of December 2021, South Africa experienced three waves of SARS-CoV-2 infections; the second and third waves were associated with circulation of Beta and Delta variants respectively. SARS-CoV-2 vaccines became available in February 2021, but uptake was low in study sites reaching 5% fully vaccinated at the end of follow up. Studies to quantify the burden of asymptomatic infections, symptomatic fraction, reinfection frequency, duration of shedding and household transmission of SARS-CoV-2 from asymptomatically infected individuals have mostly been conducted as part of outbreak investigations or in specific settings. Comprehensive systematic community studies of SARS-CoV-2 burden and transmission including for the Beta and Delta variants are lacking, especially in low vaccination settings. We conducted a unique detailed COVID-19 household cohort study over a 13 month period in South Africa, with real time reverse transcriptase polymerase chain reaction (rRT-PCR) testing twice a week irrespective of symptoms and bimonthly serology. By the end of the study in August 2021, 749 (62%) of 1200 individuals from 222 randomly sampled households in a rural and an urban community in South Africa had at least one confirmed SARS-CoV-2 infection, detected on rRT-PCR and/or serology, and 12% (87/749) experienced reinfection. Symptom data were analysed for 662 rRT-PCR-confirmed infection episodes that occurred >14 days after the start of follow-up (of a total of 718 rRT-PCR-confirmed episodes), of these, 15% (n=97) were associated with one or more symptoms. Among symptomatic indvidiausl, 9% (n=9) were hospitalised and 2% (n=2) died. Ninety percent (200/222) of included households, had one or more individual infected with SARS-CoV-2 on rRT-PCR and/or serology within the household. SARS-CoV-2 infected index cases transmitted the infection to 25% (213/856) of susceptible household contacts. Index case ribonucleic acid (RNA) viral load proxied by rRT-PCR cycle threshold value was strongly predictive of household transmission. Presence of symptoms in the index case was not associated with household transmission. Household transmission was four times greater from index cases infected with Beta variant and fifteen times greater from index cases infected with Delta variant compared to wild-type infection. Attack rates were highest in individuals aged 13-18 years and individuals in this age group were more likely to experience repeat infections and to acquire SARS-CoV-2 infection within households. People living with HIV (PLHIV) who were not virally supressed were more likely to develop symptomatic illness when infected with SARS-CoV-2, and shed SARS-CoV-2 for longer when compared to HIV-uninfected individuals. We found a high rate of SARS-CoV-2 infection in households in a rural community and an urban community in South Africa, with the majority of infections being asymptomatic in individuals of all ages. Asymptomatic individuals transmitted SARS-CoV-2 at similar levels to symptomatic individuals suggesting that interventions targeting symptomatic individuals such as symptom-based testing and contact tracing of individuals tested because they report symptoms may have a limited impact as control measures. Increased household transmission of Beta and Delta variants, likely contributed to recurrent waves of COVID-19, with >60% of individuals infected by the end of follow-up. Higher attack rates, reinfection and acquisition in adolescents and prolonged SARS-CoV-2 shedding in PLHIV who were not virally suppressed suggests that prioritised vaccination of individuals in these groups could impact community transmission.
AbstractList By August 2021, South Africa experienced three SARS-CoV-2 waves; the second and third associated with emergence of Beta and Delta variants respectively. We conducted a prospective cohort study during July 2020-August 2021 in one rural and one urban community. Mid-turbinate nasal swabs were collected twice-weekly from household members irrespective of symptoms and tested for SARS-CoV-2 using real-time reverse transcription polymerase chain reaction (rRT-PCR). Serum was collected every two months and tested for anti-SARS-CoV-2 antibodies. Among 115,759 nasal specimens from 1,200 members (follow-up rate 93%), 1976 (2%) were SARS-CoV-2-positive. By rRT-PCR and serology combined, 62% (749/1200) of individuals experienced ≥1 SARS-CoV-2 infection episode, and 12% (87/749) experienced reinfection. Of 662 PCR-confirmed episodes with available data, 15% (n=97) were associated with ≥1 symptom. Among 222 households, 200 (90%) had ≥1 SARS-CoV-2-positive individual. Household cumulative infection risk (HCIR) was 25% (213/856). On multivariable analysis, accounting for age and sex, index case lower cycle threshold value (OR 3.9, 95%CI 1.7-8.8), urban community (OR 2.0,95%CI 1.1-3.9), Beta (OR 4.2, 95%CI 1.7-10.1) and Delta (OR 14.6, 95%CI 5.7-37.5) variant infection were associated with increased HCIR. HCIR was similar for symptomatic (21/110, 19%) and asymptomatic (195/775, 25%) index cases (p=0.165). Attack rates were highest in individuals aged 13-18 years and individuals in this age group were more likely to experience repeat infections and to acquire SARS-CoV-2 infection. People living with HIV who were not virally supressed were more likely to develop symptomatic illness, and shed SARS-CoV-2 for longer compared to HIV-uninfected individuals. In this study, 85% of SARS-CoV-2 infections were asymptomatic and index case symptom status did not affect HCIR, suggesting a limited role for control measures targeting symptomatic individuals. Increased household transmission of Beta and Delta variants, likely contributed to successive waves, with >60% of individuals infected by the end of follow-up. Previous studies have generated wide-ranging estimates of the proportion of SARS-CoV-2 infections which are asymptomatic. A recent systematic review found that 20% (95% CI 3%-67%) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections remained asymptomatic throughout infection and that transmission from asymptomatic individuals was reduced. A systematic review and meta-analysis of 87 household transmission studies of SARS-CoV-2 found an estimated secondary attack rate of 19% (95% CI 16-22). The review also found that household secondary attack rates were increased from symptomatic index cases and that adults were more likely to acquire infection. As of December 2021, South Africa experienced three waves of SARS-CoV-2 infections; the second and third waves were associated with circulation of Beta and Delta variants respectively. SARS-CoV-2 vaccines became available in February 2021, but uptake was low in study sites reaching 5% fully vaccinated at the end of follow up. Studies to quantify the burden of asymptomatic infections, symptomatic fraction, reinfection frequency, duration of shedding and household transmission of SARS-CoV-2 from asymptomatically infected individuals have mostly been conducted as part of outbreak investigations or in specific settings. Comprehensive systematic community studies of SARS-CoV-2 burden and transmission including for the Beta and Delta variants are lacking, especially in low vaccination settings. We conducted a unique detailed COVID-19 household cohort study over a 13 month period in South Africa, with real time reverse transcriptase polymerase chain reaction (rRT-PCR) testing twice a week irrespective of symptoms and bimonthly serology. By the end of the study in August 2021, 749 (62%) of 1200 individuals from 222 randomly sampled households in a rural and an urban community in South Africa had at least one confirmed SARS-CoV-2 infection, detected on rRT-PCR and/or serology, and 12% (87/749) experienced reinfection. Symptom data were analysed for 662 rRT-PCR-confirmed infection episodes that occurred >14 days after the start of follow-up (of a total of 718 rRT-PCR-confirmed episodes), of these, 15% (n=97) were associated with one or more symptoms. Among symptomatic indvidiausl, 9% (n=9) were hospitalised and 2% (n=2) died. Ninety percent (200/222) of included households, had one or more individual infected with SARS-CoV-2 on rRT-PCR and/or serology within the household. SARS-CoV-2 infected index cases transmitted the infection to 25% (213/856) of susceptible household contacts. Index case ribonucleic acid (RNA) viral load proxied by rRT-PCR cycle threshold value was strongly predictive of household transmission. Presence of symptoms in the index case was not associated with household transmission. Household transmission was four times greater from index cases infected with Beta variant and fifteen times greater from index cases infected with Delta variant compared to wild-type infection. Attack rates were highest in individuals aged 13-18 years and individuals in this age group were more likely to experience repeat infections and to acquire SARS-CoV-2 infection within households. People living with HIV (PLHIV) who were not virally supressed were more likely to develop symptomatic illness when infected with SARS-CoV-2, and shed SARS-CoV-2 for longer when compared to HIV-uninfected individuals. We found a high rate of SARS-CoV-2 infection in households in a rural community and an urban community in South Africa, with the majority of infections being asymptomatic in individuals of all ages. Asymptomatic individuals transmitted SARS-CoV-2 at similar levels to symptomatic individuals suggesting that interventions targeting symptomatic individuals such as symptom-based testing and contact tracing of individuals tested because they report symptoms may have a limited impact as control measures. Increased household transmission of Beta and Delta variants, likely contributed to recurrent waves of COVID-19, with >60% of individuals infected by the end of follow-up. Higher attack rates, reinfection and acquisition in adolescents and prolonged SARS-CoV-2 shedding in PLHIV who were not virally suppressed suggests that prioritised vaccination of individuals in these groups could impact community transmission.
Author Kleynhans, Jackie
Viboud, Cécile
Wolter, Nicole
Tempia, Stefano
Sun, Kaiyun
Wafawanaka, Floidy
Tollman, Stephen
Cohen, Cheryl
Dawood, Fatimah S
von Gottberg, Anne
Mkhencele, Thulisa
McMorrow, Meredith L
du Toit, Jacques
Buys, Amelia
Martinson, Neil A
Kahn, Kathleen
Moyes, Jocelyn
du Plessis, Mignon
Lebina, Limakatso
Xavier Gómez-Olivé, Francesc
Bhiman, Jinal N
Carrim, Maimuna
Author_xml – sequence: 1
  givenname: Cheryl
  surname: Cohen
  fullname: Cohen, Cheryl
  organization: School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 2
  givenname: Jackie
  surname: Kleynhans
  fullname: Kleynhans, Jackie
  organization: School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 3
  givenname: Anne
  surname: von Gottberg
  fullname: von Gottberg, Anne
  organization: School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 4
  givenname: Meredith L
  surname: McMorrow
  fullname: McMorrow, Meredith L
  organization: Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
– sequence: 5
  givenname: Nicole
  surname: Wolter
  fullname: Wolter, Nicole
  organization: School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 6
  givenname: Jinal N
  surname: Bhiman
  fullname: Bhiman, Jinal N
  organization: School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 7
  givenname: Jocelyn
  surname: Moyes
  fullname: Moyes, Jocelyn
  organization: School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 8
  givenname: Mignon
  surname: du Plessis
  fullname: du Plessis, Mignon
  organization: School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 9
  givenname: Maimuna
  surname: Carrim
  fullname: Carrim, Maimuna
  organization: School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 10
  givenname: Amelia
  surname: Buys
  fullname: Buys, Amelia
  organization: Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
– sequence: 11
  givenname: Neil A
  surname: Martinson
  fullname: Martinson, Neil A
  organization: Johns Hopkins University Center for TB Research, Baltimore, Maryland, United States of America
– sequence: 12
  givenname: Kathleen
  surname: Kahn
  fullname: Kahn, Kathleen
  organization: MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 13
  givenname: Stephen
  surname: Tollman
  fullname: Tollman, Stephen
  organization: MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 14
  givenname: Limakatso
  surname: Lebina
  fullname: Lebina, Limakatso
  organization: Africa Health Research Institute, KwaZulu-Natal, South Africa
– sequence: 15
  givenname: Floidy
  surname: Wafawanaka
  fullname: Wafawanaka, Floidy
  organization: MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 16
  givenname: Jacques
  surname: du Toit
  fullname: du Toit, Jacques
  organization: MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 17
  givenname: Francesc
  surname: Xavier Gómez-Olivé
  fullname: Xavier Gómez-Olivé, Francesc
  organization: MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 18
  givenname: Fatimah S
  surname: Dawood
  fullname: Dawood, Fatimah S
  organization: Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
– sequence: 19
  givenname: Thulisa
  surname: Mkhencele
  fullname: Mkhencele, Thulisa
  organization: Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
– sequence: 20
  givenname: Kaiyun
  surname: Sun
  fullname: Sun, Kaiyun
  organization: Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA
– sequence: 21
  givenname: Cécile
  surname: Viboud
  fullname: Viboud, Cécile
  organization: Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA
– sequence: 22
  givenname: Stefano
  surname: Tempia
  fullname: Tempia, Stefano
  organization: Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34909794$$D View this record in MEDLINE/PubMed
BookMark eNo1UEtOwzAU9ALEp3ACJOQDNMF27KRmV0VAK1UCNYVt5djPxFLrVLaz6DG4MSmfzRvNR6PRu0ZnvveA0B0lOaWEPjDCaE6qnJGcUVaSmRAX6LLgkshK8iv01czXTVb3HxnDzmtnwGuY4hSUj3sXo-s9Vt7gAM5b0OnE3SjhMAS1-7GUx0NoxxshJec_H8dwHHYp4t7i1AF-WyzXzSarse67PiQc02COU9z0Q-rw3Aan1RSPQ0l2WnuDzq3aRbj9wwl6f37a1Its9fqyrOerTDNSigwUNUXLWgrUUmgVyLLgqlJcFUwKrgQHrbhkoiRSGctLPdMWKkGNNC1YwSbo_rf3MLR7MNtDcHsVjtv_37BvOgxhKA
CitedBy_id crossref_primary_10_1093_cid_ciab952
crossref_primary_10_1126_science_abn4947
crossref_primary_10_3390_v14061222
crossref_primary_10_1111_irv_12997
crossref_primary_10_3390_v15102100
crossref_primary_10_1038_s41467_023_36449_5
crossref_primary_10_1099_mgen_0_000993
crossref_primary_10_1001_jamanetworkopen_2022_9317
ContentType Journal Article
CorporateAuthor PHIRST group
CorporateAuthor_xml – name: PHIRST group
DBID NPM
DOI 10.1101/2021.07.20.21260855
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
ExternalDocumentID 34909794
Genre Preprint
GrantInformation_xml – fundername: ACL HHS
  grantid: U01IP001048
– fundername: Wellcome Trust
– fundername: NCIRD CDC HHS
  grantid: U01 IP001048
GroupedDBID NPM
ID FETCH-LOGICAL-c2065-ea1d3b2b1e1f1ebae9634a7a4a32954a54eca4925609adf46c8cfe751d9dbef52
IngestDate Sat Nov 02 12:30:16 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2065-ea1d3b2b1e1f1ebae9634a7a4a32954a54eca4925609adf46c8cfe751d9dbef52
OpenAccessLink http://www.thelancet.com/article/S147330992200069X/pdf
PMID 34909794
ParticipantIDs pubmed_primary_34909794
PublicationCentury 2000
PublicationDate 2021-Dec-04
PublicationDateYYYYMMDD 2021-12-04
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-Dec-04
  day: 04
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle medRxiv : the preprint server for health sciences
PublicationTitleAlternate medRxiv
PublicationYear 2021
References 35298900 - Lancet Infect Dis. 2022 Jun;22(6):821-834. doi: 10.1016/S1473-3099(22)00069-X
References_xml
Score 1.8275532
Snippet By August 2021, South Africa experienced three SARS-CoV-2 waves; the second and third associated with emergence of Beta and Delta variants respectively. We...
SourceID pubmed
SourceType Index Database
Title SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021
URI https://www.ncbi.nlm.nih.gov/pubmed/34909794
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb5swFLbSTpr6MnXafd3kh70ROnAMhL1F0absQlUl6dS3yjZGjbRBREm17V_0f-xH7hwbE1Rl2uXFIthB4PNhHx8-f4eQVyqSY8VE6hcpvE1cy8CXidJ-iBHIQOOkinHI7CSenfEP59H5YPCzx1raNPJY_di5r-R_rArnwK64S_YfLNtdFE7AMdgXSrAwlH9l48VkvvCn1WefeRgyN-lBsc8anIDAgFeOa1xrR7oyxEbh1UZtwwq1eptaQnmlG7f7GZbgmy-W5IF-6ens_Xyx9KceZtOtGytJa8KmmH_Ps6mG8DfDVSIUYd_lhel2_m117TkGyRp1NFclXAbJlrXhOdrdmF47HXdufrd3ZArI-t5xQT7CQFZetisAFAlYdei8RpGQqmkca21SbmkDmcoqpziZYYpSDEF_6oc9WGgoJHz3oG-SDWAj1GFlwTFMxzHy7_qt4SHXXw0ORjwN0iTlf669pcTtqvbIXjLGNCEnp1krZAW38HrHDRyQu-5Pt5Ytxn1ZHpJ77bqDTiyI7pOBLh-Qmy2AaAegIe3DhwJGaA8-0I4KauBjqkRJDXxoC583tAUPrQoK5qYOPNSChxrwDKmBDrXQGdIOOA_J2bu3y-nMb3N0-IqB9-prEeYjyWSowyLUUmgY0LlIBBcj_IIsIq6VQAHMOEhFXvBYjVWhkyjM01zqImKPyH5ZlfoJoSoXI9Rr5IGKecgSGTCZoni8TqQokvQpeWx78GJthVguXN8--23Nc3KwBc8RuVPAm69fgBvZyJfGfr8AFr9xBg
link.rule.ids 780
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SARS-CoV-2+incidence%2C+transmission+and+reinfection+in+a+rural+and+an+urban+setting%3A+results+of+the+PHIRST-C+cohort+study%2C+South+Africa%2C+2020-2021&rft.jtitle=medRxiv+%3A+the+preprint+server+for+health+sciences&rft.au=Cohen%2C+Cheryl&rft.au=Kleynhans%2C+Jackie&rft.au=von+Gottberg%2C+Anne&rft.au=McMorrow%2C+Meredith+L&rft.date=2021-12-04&rft_id=info:doi/10.1101%2F2021.07.20.21260855&rft_id=info%3Apmid%2F34909794&rft_id=info%3Apmid%2F34909794&rft.externalDocID=34909794